(Q84969602)
English
An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in health
scientific article published on 01 April 2010
Statements
An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age (English)
Timo Vesikari
Pierre Van Damme
Niklas Lindblad
Ulrich Pfletschinger
David Radley
Desmond Ryan
Scott Vuocolo
Richard M Haupt